Inherited Risk Evaluation Tool (InheRET): Identifying Patients at Increased Risk for Hereditary Disease

Clinical trial NCT04510896 · UNKNOWN

Trial details

NCT number: NCT04510896
Sponsor: InheRET, Inc
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hereditary Cancer-Predisposing Syndrome

Start date: 2020-09-01
Primary completion: 2022-06-30
Enrollment: 2232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.